BR0213026A - Compostos de imidazopiridina como reguladores do receptor 5-ht4 - Google Patents
Compostos de imidazopiridina como reguladores do receptor 5-ht4Info
- Publication number
- BR0213026A BR0213026A BR0213026-2A BR0213026A BR0213026A BR 0213026 A BR0213026 A BR 0213026A BR 0213026 A BR0213026 A BR 0213026A BR 0213026 A BR0213026 A BR 0213026A
- Authority
- BR
- Brazil
- Prior art keywords
- hydrogen
- alkyl
- halo
- arylalkyl
- amido
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Nutrition Science (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
"COMPOSTOS DE IMIDAZOPIRIDINA COMO REGULADORES DO RECEPTOR 5-HT~ 4~". A presente invenção proporciona um composto da fórmula (I): ou os sais farmaceuticamente aceitáveis deste, em que R^ 1^ é hidrogênio, halo ou alquilo; R^ 2^ e R^ 3^ são independentemente hidrogênio, alquilo, alcenilo, alcinilo, aminoalquilo ou hidroxi alquilo; ou R^ 2^ e R^ 3^ tomados em conjunto com o átomo de nitrogênio ao qual estão ligados podem formar um anel heterocíclico; R^ 4^ é hidrogênio, halo, acilo, amino, amido, arilo, arilalquilo ou heteroarilo; R^ 5^ é hidrogênio, halo, alquilo, alcenilo, alcinilo, acilo, amino, amido, arilo, arilalquilo ou heteroarilo; R^ 6^ é hidrogênio, alquilo ou alcoxi alquilo; X é NR^ 9^ em que R^ 9^ é hidrogênio ou alquilo; e Y é (CR^ 7^ R^ 8^)~ n~ em que n é um número inteiro de O a 5. Estes compostos possuem atividade de ligação ao receptor 5-HT~ 4~ e são, por isso, úteis para o tratamento do refluxo gastresofágico, dispepsia não ulcerosa, dispepsia funcional, síndrome do intestino irritável ou similares, em um mamífero, especialmente em seres humanos. A presente invenção proporciona também uma composição farmacêutica compreendendo os compostos acima.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34337101P | 2001-10-22 | 2001-10-22 | |
US41248502P | 2002-09-20 | 2002-09-20 | |
PCT/IB2002/004098 WO2003035649A1 (en) | 2001-10-22 | 2002-10-03 | Imidazopyridine compounds as 5-ht4 receptor modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0213026A true BR0213026A (pt) | 2004-10-05 |
Family
ID=26993446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0213026-2A BR0213026A (pt) | 2001-10-22 | 2002-10-03 | Compostos de imidazopiridina como reguladores do receptor 5-ht4 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1440071B1 (pt) |
JP (1) | JP2005526003A (pt) |
AT (1) | ATE307812T1 (pt) |
BR (1) | BR0213026A (pt) |
CA (1) | CA2461159A1 (pt) |
DE (1) | DE60206952T2 (pt) |
ES (1) | ES2248616T3 (pt) |
MX (1) | MXPA04002495A (pt) |
WO (1) | WO2003035649A1 (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0211230D0 (en) | 2002-05-16 | 2002-06-26 | Medinnova Sf | Treatment of heart failure |
BR0314584A (pt) * | 2002-09-20 | 2005-08-09 | Pfizer | Compostos piperidinil-imidazopiridina n-substituìda como moduladores e receptores 5-ht4 |
DOP2003000703A (es) * | 2002-09-20 | 2004-03-31 | Pfizer | Compuestos de imidazopiradina como agonistas del receptor 5-ht4 |
CA2523077A1 (en) * | 2003-04-21 | 2004-11-04 | Pfizer Inc. | Imidazopyridine compounds having 5-ht4 receptor agonistic activity and 5-ht3 receptor antagonistic activity |
DE102004024772A1 (de) * | 2004-05-17 | 2005-12-22 | Grünenthal GmbH | Substituierte 5-Aminomethyl-1H-pyrrol-2-carbonsäureamide |
WO2005118531A1 (en) * | 2004-06-01 | 2005-12-15 | Eli Lilly And Company | Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake |
JP5160764B2 (ja) * | 2006-10-13 | 2013-03-13 | 全薬工業株式会社 | 特定の構造の複素環化合物を含む抗鬱剤、脳保護剤、アミロイドβ沈着抑制剤または老化抑制剤 |
EP2096923B1 (en) | 2006-11-27 | 2014-01-22 | H. Lundbeck A/S | Heteroaryl amide derivatives |
US8852216B2 (en) | 2007-03-23 | 2014-10-07 | Ethicon Endo-Surgery, Inc. | Tissue approximation methods |
MY148461A (en) * | 2007-04-10 | 2013-04-30 | Lundbeck & Co As H | Heteroaryl amide analogues as p2x7 antagonists |
NZ720879A (en) | 2013-12-16 | 2017-05-26 | Suven Life Sciences Ltd | Indazole compounds as 5-ht4 receptor agonists |
US10570135B2 (en) | 2014-11-06 | 2020-02-25 | Lysosomal Therapeutics Inc. | Substituted pyrazolo[1,5-A]pyrimidines and their use in the treatment of medical disorders |
WO2016073891A1 (en) | 2014-11-06 | 2016-05-12 | Lysosomal Therapeutics Inc. | Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders |
US20170333435A1 (en) | 2014-11-06 | 2017-11-23 | Lysosomal Therapeutics Inc. | Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders |
CN106146386A (zh) * | 2015-04-21 | 2016-11-23 | 江苏威凯尔医药科技有限公司 | 一种制备普卡必利中间体的新工艺 |
CA3020310A1 (en) | 2016-04-06 | 2017-10-12 | Lysosomal Therapeutics Inc. | Pyrrolo[1,2-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders |
US10787454B2 (en) | 2016-04-06 | 2020-09-29 | BIAL—BioTech Investments, Inc. | Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders |
AU2017246455B2 (en) | 2016-04-06 | 2021-09-30 | Bial - R&D Investments, S.A. | Pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders |
US11345698B2 (en) | 2016-05-05 | 2022-05-31 | Bial—R&D Investments, S.A. | Substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-a]pyrazines, related compounds, and their use in the treatment of medical disorders |
AU2017261291C1 (en) | 2016-05-05 | 2022-05-26 | Bial - R&D Investments, S.A. | Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disorders |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5260303A (en) * | 1991-03-07 | 1993-11-09 | G. D. Searle & Co. | Imidazopyridines as serotonergic 5-HT3 antagonists |
GB9221468D0 (en) * | 1992-10-13 | 1992-11-25 | Smithkline Beecham Plc | Pharmaceuticals |
-
2002
- 2002-10-03 MX MXPA04002495A patent/MXPA04002495A/es unknown
- 2002-10-03 DE DE60206952T patent/DE60206952T2/de not_active Expired - Fee Related
- 2002-10-03 BR BR0213026-2A patent/BR0213026A/pt not_active IP Right Cessation
- 2002-10-03 CA CA002461159A patent/CA2461159A1/en not_active Abandoned
- 2002-10-03 JP JP2003538165A patent/JP2005526003A/ja not_active Withdrawn
- 2002-10-03 AT AT02777598T patent/ATE307812T1/de not_active IP Right Cessation
- 2002-10-03 ES ES02777598T patent/ES2248616T3/es not_active Expired - Lifetime
- 2002-10-03 EP EP02777598A patent/EP1440071B1/en not_active Expired - Lifetime
- 2002-10-03 WO PCT/IB2002/004098 patent/WO2003035649A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
DE60206952T2 (de) | 2006-06-22 |
WO2003035649A1 (en) | 2003-05-01 |
JP2005526003A (ja) | 2005-09-02 |
EP1440071B1 (en) | 2005-10-26 |
EP1440071A1 (en) | 2004-07-28 |
ES2248616T3 (es) | 2006-03-16 |
MXPA04002495A (es) | 2004-05-31 |
CA2461159A1 (en) | 2003-05-01 |
DE60206952D1 (de) | 2005-12-01 |
ATE307812T1 (de) | 2005-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0213026A (pt) | Compostos de imidazopiridina como reguladores do receptor 5-ht4 | |
BRPI0507180A (pt) | derivados de 1-isopropil-2-oxo-1,2-diidropiridina-3-carboxamida tendo atividade agonìstica de receptor 5-ht4 | |
AR036906A1 (es) | Compuestos de imidazopiridin como moduladores del receptor 5-ht4 | |
MXPA05011270A (es) | Compuestos de imidazopiridina que tienen actividad agonista del receptor 5-ht4 y actividad antagonista del receptor 5-ht3. | |
HUP0400828A2 (hu) | Kondenzált heterociklikus aminopirimidinek, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
HUP0002461A2 (hu) | Triciklusos benzotiepin- vagy benzoxepinszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
EE200300403A (et) | N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina | |
FR2842804B1 (fr) | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique | |
DE60211343D1 (de) | Derivate von triazolyl-imidazopyridine und von triazolylpurine als ligande des adenosine a2a rezeptoren und ihre verwendung als medicamente | |
EA200700099A1 (ru) | Производные пиридина | |
HUP0301573A2 (hu) | Szubsztituált arilpirazinok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
RS101304A (sr) | Indolni, azaindolni i srodni heterociklični 4-alkenil piperidinski amidi | |
HUP0100388A2 (hu) | Készítmények és eljárások csontritkulás kezelésére és a koleszterinszint csökkentésére | |
EA200801134A1 (ru) | Замещенные бициклические пиримидоновые производные | |
DE60237528D1 (de) | Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative | |
MXPA02011417A (es) | 1-aminoalquil-lactamas sustituidas y su uso como antagonistas de receptores muscarinicos. | |
IS8377A (is) | Arýlindenópyridín og arýlindenópyrimidín og notkun þeirra sem mótlyf A2A viðtaka adenósíns | |
EA200400467A1 (ru) | Производные 3-азабицикло (3.1.0) гексана в качестве антагонистов опиоидного рецептора | |
NO20075617L (no) | 4-fenyl-5-okso-1,4,5,6,7,8-heksahydrokinolinderivater for behandling av infertilitet | |
MXPA02011418A (es) | 1-aminoalquil-lactamas sustituidas y su uso como antagonistas del receptor muscarinico. | |
DE602004031722D1 (de) | Kondensierte bizyklisch substituierte amine als histamin 3 rezeptor liganden | |
NO20040589L (no) | Arylsulfonylderivater med 5-HT6 reseptor affinitet. | |
DE60001586D1 (de) | Diphenyl-piperidin derivate | |
NO20063562L (no) | Fusjonerte heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
RU2004130284A (ru) | Антипаразитарные производные артемизинина (эндопероксиды) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1971 DE 14/10/2008. |